Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Blood|October 3, 2007
Postsurgery outcomes in patients with polycythemia vera and essential thrombocythemia: a retrospective surveyMarco Ruggeri, Francesco Rodeghiero, Alberto Tosetto, et al.
Cancer|July 13, 2012
Prognostic factors associated with progression of smoldering multiple myeloma to symptomatic formAngela Rago, Sara Grammatico, Tommaso Za, et al.
British Journal of Haematology|December 18, 2012
Arterial and venous thrombosis in patients with monoclonal gammopathy of undetermined significance: incidence and risk factors in a cohort of 1491 patientsTommaso Za, Valerio De Stefano, Elena Rossi, et al.
American Journal of Hematology|January 7, 2010
Leukocytosis is a risk factor for recurrent arterial thrombosis in young patients with polycythemia vera and essential thrombocythemiaValerio De Stefano, Tommaso Za, Elena Rossi, et al.
Annals of Hematology|July 8, 2009
Increased risk of recurrent thrombosis in patients with essential thrombocythemia carrying the homozygous JAK2 V617F mutationValerio De Stefano, Tommaso Za, Elena Rossi, et al.
Annals of Hematology|October 11, 2025
Infection events in patients with newly diagnosed multiple myeloma with anti-CD38 monoclonal antibody-based first line regimens: A multicentric Italian experienceAngela Rago, Francesca Fioritoni, Carmine Liberatore, et al.
Haematologica|February 13, 2008
Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatmentsValerio De Stefano, Tommaso Za, Elena Rossi, et al.
Cancers|April 13, 2023
Consensus for Flow Cytometry Clinical Report on Multiple Myeloma: A Multicenter Harmonization Process Merging Laboratory Experience and Clinical NeedsIole Cordone, Rachele Amodeo, Silvia Bellesi, et al.
American Journal of Hematology|April 5, 2012
Hydroxyurea-related toxicity in 3,411 patients with Ph'-negative MPNElisabetta Antonioli, Paola Guglielmelli, Lisa Pieri, et al.
Cancers|November 13, 2025
The Strange Case of Functional High-Risk Multiple Myeloma Patients: Is It Possible to Identify Them in Clinical Practice?Sonia Morè, Massimo Offidani, Laura Corvatta, et al.
Pageof 4